Literature DB >> 10991882

[(1)N,(12)N]Bis(Ethyl)-cis-6,7-dehydrospermine: a new drug for treatment and prevention of Cryptosporidium parvum infection of mice deficient in T-cell receptor alpha.

W R Waters1, B Frydman, L J Marton, A Valasinas, V K Reddy, J A Harp, M J Wannemuehler, N Yarlett.   

Abstract

Cryptosporidium parvum infection of T-cell receptor alpha (TCR-alpha)-deficient mice results in a persistent infection. In this study, treatment with a polyamine analogue (SL-11047) prevented C. parvum infection in suckling TCR-alpha-deficient mice and cleared an existing infection in older mice. Treatment with putrescine, while capable of preventing infection, did not clear C. parvum from previously infected mice. These findings provide further evidence that polyamine metabolic pathways are targets for new anticryptosporidial chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991882      PMCID: PMC90173          DOI: 10.1128/AAC.44.10.2891-2894.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice.

Authors:  J R Mead; M J Arrowood; R W Sidwell; M C Healey
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

Review 2.  Role of polyamines in gastrointestinal mucosal growth.

Authors:  S A McCormack; L R Johnson
Journal:  Am J Physiol       Date:  1991-06

Review 3.  Polyamines in microorganisms.

Authors:  C W Tabor; H Tabor
Journal:  Microbiol Rev       Date:  1985-03

Review 4.  Parasitisms of dairy and beef cattle in the United States.

Authors:  C R Reinemeyer
Journal:  J Am Vet Med Assoc       Date:  1994-09-01       Impact factor: 1.936

5.  Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study.

Authors:  R Mancassola; J M Reperant; M Naciri; C Chartier
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Potential risk factors for Cryptosporidium infection in dairy calves.

Authors:  L P Garber; M D Salman; H S Hurd; T Keefe; J L Schlater
Journal:  J Am Vet Med Assoc       Date:  1994-07-01       Impact factor: 1.936

7.  A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply.

Authors:  W R Mac Kenzie; N J Hoxie; M E Proctor; M S Gradus; K A Blair; D E Peterson; J J Kazmierczak; D G Addiss; K R Fox; J B Rose
Journal:  N Engl J Med       Date:  1994-07-21       Impact factor: 91.245

8.  A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa).

Authors:  S J Upton; M Tilley; M V Nesterenko; D B Brillhart
Journal:  FEMS Microbiol Lett       Date:  1994-05-01       Impact factor: 2.742

9.  Resistance of severe combined immunodeficient mice to infection with Cryptosporidium parvum: the importance of intestinal microflora.

Authors:  J A Harp; W Chen; A G Harmsen
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

10.  Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.

Authors:  K R Rasmussen; M C Healey; L Cheng; S Yang
Journal:  J Parasitol       Date:  1995-06       Impact factor: 1.276

View more
  6 in total

Review 1.  Recent advances in the development of polyamine analogues as antitumor agents.

Authors:  Robert A Casero; Patrick M Woster
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

2.  Activities of DL-alpha-difluoromethylarginine and polyamine analogues against Cryptosporidium parvum infection in a T-cell receptor alpha-deficient mouse model.

Authors:  Nigel Yarlett; W Ray Waters; James A Harp; Michael J Wannemuehler; Mary Morada; Josephine Bellcastro; Steve J Upton; Laurence J Marton; Benjamin J Frydman
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

3.  Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.

Authors:  Michael W Riggs; Deborah A Schaefer; Sushila J Kapil; Lise Barley-Maloney; Lance E Perryman
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in a SCID mouse model.

Authors:  Xiaochuan Feng; Venudhar K Reddy; Harriet Mayanja-Kizza; Louis M Weiss; Laurence J Marton; Saul Tzipori
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

Review 5.  Design of polyamine-based therapeutic agents: new targets and new directions.

Authors:  M D Thulani Senanayake; Hemali Amunugama; Tracey D Boncher; Robert A Casero; Patrick M Woster
Journal:  Essays Biochem       Date:  2009-11-04       Impact factor: 8.000

6.  In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells.

Authors:  Amy Hacker; Laurence J Marton; Michelle Sobolewski; Robert A Casero
Journal:  Cancer Chemother Pharmacol       Date:  2008-02-27       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.